Review of tissue-resident memory T cell features in cancer and autoimmune diseases

This source is a narrative review focusing on tissue-resident memory T cells (Trm cells) in the context of cancer and autoimmune diseases. The scope encompasses the developmental differentiation and molecular features of these cells within the tumor microenvironment and autoimmune disease settings. No specific sample size or primary outcomes were reported in this synthesis.

The authors discuss the biological characteristics of Trm cells but did not provide pooled effect sizes or specific quantitative data regarding interventions or comparators. Consequently, no specific adverse events, tolerability, or discontinuation rates are described in this text. The review aims to consolidate qualitative knowledge rather than present trial-level efficacy data.

Limitations acknowledged by the authors or inherent to the source include the absence of reported safety data, follow-up periods, and specific outcome measures. Because the study type is a review and not a randomized controlled trial, causal language regarding treatment effects is avoided. The certainty of findings is constrained by the lack of reported numerical data and the narrative nature of the synthesis.